We recognize that our products are critical for our customers, and ultimately for the well-being of the treated patient receiving allergy diagnostics or allergy specific immunotherapy. Due to the high complexity of our products and the increasingly challenging regulatory environment, we believe that working closely with our customers is a requirement for a successful business.
Our business model sets out to form partnerships with our industrial customers facilitating information flow and innovation, thereby increasing the value for both parties. Our wish is to be an integral part of our customers’ supply as well as be the natural partner for product development and regulatory support.
We understand the need of well standardized allergen source materials for start-ups, small commercial players and academic institutions. We strive to accommodate supply needs as far as possible, even for very low volumes and non-forecasted supply to the scientific community. However, due to the resources required, we will not always be able to accommodate quick turnaround deliveries in these circumstances.
Using our abilities, we strive to be the natural partner for not only successful supply of allergens used for allergy diagnostics and allergy immunotherapy, but also for product development, supply chain management and regulatory support.